VKTX
Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note
In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $29.73, denoting a +0.61% change from...
Read moreDetails
Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know
In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $29.10, indicating a +1.46% shift from the previous...
Read moreDetails
Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note
In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $28.87, denoting a +0.7% change from...
Read moreDetails
Is Viking Therapeutics a Buy Right Now?
Viking Therapeutics (VKTX -3.01%) soared into the spotlight about a year ago when it delivered promising data on a drug...
Read moreDetails
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months — and It’s Not Eli Lilly or Novo Nordisk
Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly...
Read moreDetails
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?
Nearly a year ago, Viking Therapeutics (VKTX 3.50%) shares exploded higher after the clinical-stage drugmaker announced successful results from a...
Read moreDetails
VKTX’s Q4 Loss Wider Than Expected, Sales Nil, Stock Down 10%
Viking Therapeutics' fourth-quarter earnings miss estimates. The decline in stock price was attributable to a lack of material updates on...
Read moreDetails
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. – VKTX
NEW YORK , Jan. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Viking Therapeutics,...
Read moreDetails
1 Under-the-Radar Stock to Buy Before It Soars by 156%, According to Select Wall Street Analysts
In this video, I will cover the recent updates regarding Viking Therapeutics (VKTX 1.26%). Watch the short video to learn...
Read moreDetails
Why Viking Therapeutics Stock Plummeted by 24% in December
Viking Therapeutics (VKTX 4.30%) didn't exactly capture investors' hearts in the final month of 2024. The biotech company's share price...
Read moreDetails